These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36302708)

  • 1. Retrospective study on the effectiveness and safety of the shortened 5- to 7-day antibiotic regimen for acute streptococcal pharyngotonsillitis compared to the classic 10-day regimen.
    Salinas Salvador B; Moreno Sánchez A; Carmen Marcén G; Molina Herranz D; Arana Navarro T; García Vera C
    An Pediatr (Engl Ed); 2022 Dec; 97(6):398-404. PubMed ID: 36302708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens.
    Brook I
    Paediatr Drugs; 2002; 4(11):747-54. PubMed ID: 12390046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of Group A streptococcal isolates causing scarlet fever and pharyngitis among young children: a retrospective study from a northern Taiwan medical center.
    Wu PC; Lo WT; Chen SJ; Wang CC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):304-10. PubMed ID: 23639381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group A streptococcal pharyngitis and immune-mediated complications: from diagnosis to management.
    Shulman ST; Tanz RR
    Expert Rev Anti Infect Ther; 2010 Feb; 8(2):137-50. PubMed ID: 20109044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.
    Skoog Ståhlgren G; Tyrstrup M; Edlund C; Giske CG; Mölstad S; Norman C; Rystedt K; Sundvall PD; Hedin K
    BMJ; 2019 Oct; 367():l5337. PubMed ID: 31585944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scarlet fever: A not so typical exanthematous pharyngotonsillitis (based on 171 cases).
    García-Vera C; de Dios Javierre B; Castán Larraz B; Arana Navarro T; Cenarro Guerrero T; Ruiz Pastora R; Sánchez Gimeno J
    Enferm Infecc Microbiol Clin; 2016; 34(7):422-6. PubMed ID: 26585817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group C beta-hemolytic streptococci causing pharyngitis and scarlet fever.
    Corson AP; Garagusi VF; Chretien JH
    South Med J; 1989 Sep; 82(9):1119-21. PubMed ID: 2772682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In response to the article "Retrospective study on the effectiveness and safety of the shortened 5- to 7 day antibiotic regimen for acute streptococcal pharyngotonsillitis compared to the classic 10-day regimen".
    Alonso-Cadenas JA; Andina Martínez D; León de Loinaz O; Molina Cabañero JC
    An Pediatr (Engl Ed); 2024 Jun; 100(6):e17-e18. PubMed ID: 38490908
    [No Abstract]   [Full Text] [Related]  

  • 9. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group.
    O'Doherty B
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):718-24. PubMed ID: 8922571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term treatment of streptococcal tonsillitis with ceftriaxone.
    Pavesio D; Pecco P; Peisino MG
    Chemotherapy; 1988; 34 Suppl 1():34-8. PubMed ID: 3246169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group.
    Pichichero ME; Mclinn SE; Gooch WM; Rodriguez W; Goldfarb J; Reidenberg BE
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S102-7. PubMed ID: 7567309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of josamycin for the treatment of scarlet fever and hemolytic-streptococcal tonsillitis].
    Yanagishita T; Shimizu N; Ono T
    Nihon Densenbyo Gakkai Zasshi; 1969 Nov; 43(8):205-12. PubMed ID: 4983145
    [No Abstract]   [Full Text] [Related]  

  • 14. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
    Casey JR; Pichichero ME
    Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children.
    Di Pierro F; Colombo M; Giuliani MG; Danza ML; Basile I; Bollani T; Conti AM; Zanvit A; Rottoli AS
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4601-4606. PubMed ID: 27874935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children.
    Altamimi S; Khalil A; Khalaiwi KA; Milner RA; Pusic MV; Al Othman MA
    Cochrane Database Syst Rev; 2012 Aug; (8):CD004872. PubMed ID: 22895944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a short-course antibiotic treatment effective for streptococcal tonsillopharyngitis in children?
    Rojas-Ramírez C; Kramer-Urrutia T; Cifuentes L
    Medwave; 2017 Mar; 17(Suppl1):e6873. PubMed ID: 28777783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
    Quinn J; Ruoff GE; Ziter PS
    Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-Label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/tonsillitis.
    Brook I; Aronovitz GH; Pichichero ME
    Clin Ther; 2001 Nov; 23(11):1889-900. PubMed ID: 11768840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic management of group A streptococcal pharyngotonsillitis.
    Bass JW
    Pediatr Infect Dis J; 1991 Oct; 10(10 Suppl):S43-9. PubMed ID: 1945596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.